• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number ENVPRO-16-US
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/20/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This report is being submitted as part of remediation activities associated with capa 643143, addressing mdr reporting guidance from the fda¿s 1995 preamble, which ensures complaints related to corrections and recalls previously reported to the fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Product analysis: upon receipt of the suspect complaint device at medtronic¿s quality laboratory, visual analysis showed the handle components detached from the dcs.The device was received with the capsule partially open.The capsule appears intact with no evidence of damage.The trigger moves to fully advance and retracted positions and locks in place when released.The tip-retrieval mechanism appears intact.The device was returned with the end cap/screw gear snap fit connected.Damage is observed on the inner member near the spindle hub.Both tabs on the actuator component appear to be hinging inwards.The carriage components appear intact with no evidence of damage.Conclusion: the device history record was reviewed and showed this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The device was returned to medtronic for analysis and was received with the handle components detached from the dcs.Thus, confirming the reported complaint.Damage was also observed on the inner member near the spindle hub.The description of the event does not indicate that this damage occurred during the reported issue.Both tabs on the actuator component were observed to be hinging inwards.Actuator separation is typically associated with broken or damaged snap fit tabs, either one tab or both, which hold the handle together.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve, the delivery catheter system (dcs) was unpackaged and prepped in the usual fashion.It was reported that the handle of the dcs felt a little wobbly when opening the capsule, but it was intact.A 29mm valve was prepped and loaded into the compression loading system (cls) without incident.The valve was loaded onto the dcs and the capsule advanced over the valve paddles and outflow crowns easily.However, once the capsule reached the commissures and tissue portion of the valve, resistance was felt and the handle split in half along the seams.The valve was unloaded from the dcs and not used for implant.A new dcs was prepped and the valve loaded without incident.Loading was performed by an experienced loader.It was noted that both deployment knobs were bent, but both were attached.It was also noted that the deployment knob trigger was used to move the handle back to open the capsule.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVEO PRO DELIVERY SYSTEM
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key22412364
Report Number2025587-2025-04800
Device Sequence Number18244560
Product Code NPT
UDI-Device Identifier00643169987210
UDI-Public(01)00643169987210(17)200425(10)0009109802
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date (Section B) 07/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/25/2020
Device Model NumberENVPRO-16-US
Device Catalogue NumberENVPRO-16-US
Device Lot Number0009109802
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/08/2018
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/03/2021
Initial Report FDA Received Date07/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/26/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
2025587-05-28-2021-001-R
Patient Sequence Number1
Patient SexMale
-
-